PP_1170x120_10-25-21

Nick Hart

Lupin appoints Hart president – specialty for U.S. business

Lupin appoints Hart president – specialty for U.S. business

BALTIMORE — Lupin announced the appointment of Nicholas (Nick) Hart as president – specialty for its U.S. business. Hart will lead the specialty strategic business unit in the United States and will be responsible for Lupin’s specialty brand business growth strategy, P&L and organization. Hart brings over 25 years of specialty business, strategic and commercial operations experience to

Lupin’s Solosec now available in U.S. pharmacies

Lupin’s Solosec now available in U.S. pharmacies

BALTIMORE — Lupin Pharmaceuticals Inc. announced that Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women is now available to patients across the United States. Solosec, the first new oral antibiotic to treat BV in more than a decade, is the only single 2g oral dose therapy for the